Point72 Asset Management
MDGL icon

Point72 Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Point72 Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.6M Sell
137,029
-88,481
-39% -$45.3M 0.08% 292
2026
Q1 		$118M Buy
225,510
+99,075
+78% +$47.3M 0.15% 139
2025
Q4 		$73.6M Buy
126,435
+85,202
+207% +$43.5M 0.08% 269
2025
Q3 		$18.9M Sell
41,233
-69,644
-63% -$26M 0.03% 574
2025
Q2 		$33.6M Buy
110,877
+45,017
+68% +$13.4M 0.07% 336
2025
Q1 		$21.8M Buy
+65,860
New +$21.6M 0.05% 429
2024
Q3 		– Sell
-40,958
Closed -$11.5M – 2206
2024
Q2 		$11.5M Sell
40,958
-52,613
-56% -$12.5M 0.03% 563
2024
Q1 		$25M Buy
+93,571
New +$22M 0.06% 381
2023
Q4 		– Sell
-172,900
Closed -$25.3M – 2542
2023
Q3 		$25.3M Buy
+172,900
New +$32.5M 0.07% 340
2023
Q2 		– Sell
-3,993
Closed -$967K – 2527
2023
Q1 		$967K Buy
+3,993
New +$1.09M ﹤0.01% 1113
2022
Q4 		– Sell
-22,876
Closed -$1.49M – 1684
2022
Q3 		$1.49M Buy
+22,876
New +$1.59M 0.01% 994
2021
Q4 		– Sell
-30,100
Closed -$2.4M – 1214
2021
Q3 		$2.4M Buy
+30,100
New +$2.6M 0.01% 773
2020
Q2 		– Sell
-78,900
Closed -$5.27M – 931
2020
Q1 		$5.27M Buy
+78,900
New +$6.57M 0.04% 376
2019
Q4 		– Sell
-30,521
Closed -$2.63M – 1128
2019
Q3 		$2.63M Sell
30,521
-27,379
-47% -$2.57M 0.02% 557
2019
Q2 		$6.07M Buy
57,900
+37,133
+179% +$3.98M 0.03% 470
2019
Q1 		$2.6M Sell
20,767
-32,233
-61% -$4.01M 0.01% 671
2018
Q4 		$5.97M Sell
53,000
-41,800
-44% -$6.47M 0.03% 519
2018
Q3 		$20.3M Buy
+94,800
New +$23.8M 0.08% 295
2018
Q2 		– Sell
-39,900
Closed -$4.66M – 1104
2018
Q1 		$4.66M Sell
39,900
-80,100
-67% -$9.89M 0.02% 589
2017
Q4 		$11M Buy
+120,000
New +$6.85M 0.05% 427

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management's MDGL Position: Q2 2026 in Review

Point72 Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 39% in Q2 2026, selling an estimated $45.3M and leaving 137,029 shares worth $73.6M. The position accounts for 0.08% of the portfolio, ranked #292.

Point72 Asset Management first reported a position in MDGL in Q4 2017 and has held it in 20 quarters since. The position peaked at $118M in Q1 2026. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Point72 Asset Management held 137,029 shares of Madrigal Pharmaceuticals worth $73.6M as of Q2 2026.
  • Point72 Asset Management sold 88,481 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $45.3M.
  • Madrigal Pharmaceuticals made up 0.08% of Point72 Asset Management's portfolio in Q2 2026, its #292 holding.
  • Point72 Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • Point72 Asset Management's Madrigal Pharmaceuticals position peaked at $118M in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.